XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements (Tables)
 9 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Recurring Fair Value Measurements The financial instruments measured at fair value in the accompanying condensed consolidated balance sheets consist of the following:
Recurring Fair Value Measurements
as of December 31, 2022
Level 1Level 2Level 3Total
Assets:
Current derivative instruments (2)
$— $11,483 $— $11,483 
Long-term deferred compensation plan asset (1)
19,392 — — 19,392 
Long term derivative instruments (2)
— 6,518 — 6,518 
Total Assets$19,392 $18,001 $— $37,393 
Liabilities:
Long-term deferred compensation plan liability (1)
19,392 — — 19,392 
Total Liabilities$19,392 $— $— $19,392 
Recurring Fair Value Measurements
as of March 31, 2022
Level 1Level 2Level 3Total
Assets:
Long-term deferred compensation plan asset (1)
$16,512 $— $— $16,512 
Long term derivative instruments (2)
— 4,088 — 4,088 
Total Assets$16,512 $4,088 $— $20,600 
Liabilities:
Current derivative instruments (2)
$— $4,324 $— $4,324 
Long-term derivative instruments (2)
— 39 — 39 
Long-term deferred compensation plan liability (1)
16,512 — — 16,512 
Total Liabilities$16,512 $4,363 $— $20,875 
(1) Investments in this category consist primarily of mutual funds whose fair values are determined by reference to the quoted market price per unit in active markets multiplied by the number of units held without consideration of transaction costs. These assets and liabilities represent investments held in a consolidated trust to fund the Company's non-qualified deferred compensation plan and are recorded in other long-term assets and other long-term liabilities on our condensed consolidated balance sheets.
(2) The Company’s interest rate swaps are considered over-the-counter derivatives and fair value is estimated based on the present value of future cash flows using a model-derived valuation that uses Level 2 observable inputs such as interest rate yield curves. See Note 9, “Derivatives,” to the condensed consolidated financial statements for further discussion on the Company’s derivative instruments designated as cash flow hedges.
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments The carrying amount and estimated fair value of debt consists of the following:
December 31, 2022March 31, 2022
Carrying AmountEstimated Fair ValueCarrying AmountEstimated Fair Value
New Term Loan A$1,639,688 $1,602,795 $— $— 
Existing Term Loan A Loans— — 1,241,398 1,218,122 
Existing Term Loan B Loans— — 380,321 379,461 
3.88% Senior Notes due 2028
700,000 624,092 700,000 676,228 
4.00% Senior Notes due 2029
500,000 443,125 500,000 488,335